News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Benjamin Schlechter Will Present New Long-Term Follow-Up Data from the Phase 1 Study With MSS – Agenus
Agenus/LinkedIn
Jun 27, 2025, 09:53

Benjamin Schlechter Will Present New Long-Term Follow-Up Data from the Phase 1 Study With MSS – Agenus

Agenus shared on LinkedIn:

“Looking ahead to ESMOGI25: Dr. Benjamin Schlechter from Dana-Farber Cancer Institute will present new long-term follow-up data from the Phase 1 study with microsatellite stable (MSS) metastatic colorectal cancer patients.
Stop by our poster next week at the 2025 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress in Barcelona, Spain.

Learn more about the abstract.”

More posts featuring ESMOGI25.

Benjamin Schlechter cancer colorectal cancer CRC Dana-Farber Cancer Institute ESMO ESMOGI25 European Society for Medical Oncology MSS OncoDaily Oncology
Special Coverage
Insight
Aug 8, 2025, 07:59
Adrian Pogacian: Fear Comes as Natural, But Hope is Learned!
Drugs
Aug 8, 2025, 07:08
Adagrasib (Krazati) Updates 2025: Uses in Cancer, Side Effects, Dosages, Expectations, and More
Career
Aug 8, 2025, 06:20
Joseph Contessa Selected as the Chair of Radiation Oncology at Rutgers Cancer Institute
Dialogues
Aug 8, 2025, 06:16
Accelerating Cancer Drug Development with AI: Interview with Dr. Jen-Tang (JT) Lu from Vysioneer
Blog
Aug 8, 2025, 06:08
Better-Targeted Therapies for Patients with Acute Myeloid Leukemia - IU Simon Comprehensive Cancer Center
Blog
Aug 8, 2025, 05:59
The Silver Jubilee of the Townsville to Cairns Bike Ride: Raising Funds for Childhood Cancer - Children's Cancer Institute
Insight
Aug 8, 2025, 05:47
FASCO 2025: 97 Voices, One Mission: Part 2
Science
Aug 8, 2025, 05:44
Yan Leyfman: Turning Paradoxical Biology Into Precision Immunotherapy Opportunities
Science
Aug 8, 2025, 05:01
Arndt Vogel: ESMO-MCBS 2.0 Scorecards for Hepatocellular Carcinoma
Oncolibrary
Aug 8, 2025, 03:13
CAR T-Cell Therapy vs iNKT Cell Therapy: The Future of Engineered Immune Cells in Cancer Treatment
Oncolibrary
Aug 8, 2025, 03:09
Immunotherapy for Cancer Success Rate: What Patients Need to Know in 2025
Oncolibrary
Aug 8, 2025, 01:07
10-Minute Immunotherapy Infusion: Safe, Efficient Delivery of Nivolumab and Pembrolizumab